Taken together, these reports support and suggest a role for the 1p36 locus and ARID1A, in neuroblastoma tumor development, where loss of ARID1A modulates onset and invasiveness and induces a mesenchymal tumor phenotype that might increase resistance to chemotherapy (Figure 2). This evidence concerns the gene ARID1A and neoplasm.